[1]
Q. M. Ali, S. H. Raza, A. Imran, S. Anjum, and M. Masroor, “Efficacy and safety of sofosbuvir plus ribavirin in treatment-naive chronic hepatitis c genotype 3 patients of South Punjab, Pakistan”, Int J Res Med Sci, vol. 8, no. 12, pp. 4242–4246, Nov. 2020.